Non-AIDS-related Kaposi's sarcoma: A single-institution experience

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

359

HTML

3478

Figures (1-1)

574

Tables (1-4)

599

Sum=5010

Publishing Process of This Article

Item

Count

Browse

1013

Download

889

Sum=1902

May 10, 2013 (publication date) through Feb 18, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Clin Oncol. May 10, 2013; 4(2): 52-57
Published online May 10, 2013. doi: 10.5306/wjco.v4.i2.52

Table 2 Chemotherapy agents employed in the sample population n (%)

	Patients number
Sytemic treatment¹
Vinblastine	17 (53.1)
Pegylated liposomal doxorubicin	8 (25)
Paclitaxel	5 (15.6)
Gemcitabine	1 (3.1)
Vinorelbine	1 (3.1)
Overall number of lines of systemic treatment received by the patient
1 line	26 (81.2)
> 1 line	6 (18.8)

¹The first systemic treatment delivered at our institution is reported.

Citation: Rescigno P, Trolio RD, Buonerba C, Fata GD, Federico P, Bosso D, Virtuoso A, Izzo M, Policastro T, Vaccaro L, Cimmino G, Perri F, Matano E, Delfino M, Placido SD, Palmieri G, Lorenzo GD. Non-AIDS-related Kaposi's sarcoma: A single-institution experience. World J Clin Oncol 2013; 4(2): 52-57
URL: https://www.wjgnet.com/2218-4333/full/v4/i2/52.htm
DOI: https://dx.doi.org/10.5306/wjco.v4.i2.52